NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arvinas, Inc. ("Arvinas" or "the Company") (NASDAQ:ARVN). Investors who purchased Arvinas securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ARVN.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Wabash National Corporation ("Wabash" or "the Company") (NYSE:WNC). Investors who purchased Wabash securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WNC.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE:SLQT). Investors who purchased SelectQuote securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SLQT.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of D-Wave Quantum Inc. ("D-Wave" or "the Company") (NYSE:QBTS). Investors who purchased D-Wave securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/QBTS.

NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Krispy Kreme, Inc. ("Krispy Kreme" or "the Company") (NASDAQ:DNUT). Investors who purchased Krispy Kreme securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/DNUT.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Iovance Biotherapeutics, Inc. ("Iovance" or "the Company") (NASDAQ:IOVA). Investors who purchased Iovance securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IOVA.

NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ichor Holdings, Ltd. ("Ichor" or "the Company") (NASDAQ:ICHR).

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cable One, Inc. ("Cable One" or "the Company") (NYSE:CABO). Investors who purchased Cable One securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CABO.

NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PTC Therapeutics, Inc. ("PTC" or "the Company") (NASDAQ:PTCT). Investors who purchased PTC securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTCT.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jack in the Box Inc. ("Jack in the Box" or "the Company") (NASDAQ:JACK). Investors who purchased Jack in the Box securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/JACK.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amerant Bancorp Inc. ("Amerant" or "the Company") (NYSE:AMTB). Investors who purchased Amerant securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AMTB.

NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myriad Genetics, Inc. ("Myriad Genetics, Inc." or "the Company") (NASDAQ:MYGN). Investors who purchased Myriad Genetics, Inc. securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MYGN.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Watsco, Inc. ("Watsco" or "the Company") (NYSE: WSO). Investors who purchased Watsco securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WSO.

NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Organon & Co. ("Organon" or "the Company") (NYSE: OGN). Investors who purchased Organon securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OGN.

LITTLE ROCK, Ark.--(BUSINESS WIRE)-- #BartkoPavia--Bartko Pavia LLP trial team, led by Patrick M. Ryan, achieves a landmark victory for Zest Labs, Inc. against Walmart.

NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EchoStar Corporation ("EchoStar" or "the Company") (NASDAQ:SATS). Investors who purchased EchoStar securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SATS.

Shares of Super Micro Computer rallied sharply in early trading Wednesday, extending gains from the previous session, as a combination of favourable analyst coverage, a multibillion-dollar AI infrastructure deal, and improved geopolitical sentiment lifted investor confidence in the server maker. The stock opened more than 18% higher at $45.

Tesla Inc (NASDAQ:TSLA)'s board has formed a special committee to evaluate CEO Elon Musk's compensation, which could lead to a new stock options package, The Financial Times (FT) reported, citing people familiar with the matter. The committee comprises board chair Robyn Denholm and independent director Kathleen Wilson-Thompson, and was established to assess alternative ways to compensate Musk in the event his voided 2018 pay deal is not reinstated through appeal.

Reported cumulative MMR rate of 44% (16 of 36) by 24 weeks with 26% (7 of 27) of patients achieving MMR by 24 weeks, which continues to compare favorably to precedent Phase 1 trials of approved BCR::ABL1 TKIs ELVN-001 continues to demonstrate a favorable safety and tolerability profile across all dose levels with 74 patients enrolled and a median treatment duration of ~26 weeks at cutoff Presentation at EHA will include updated data with additional patients and longer treatment duration Enliven will host a webcast and conference call on June 13 at 1:30 p.m. ET BOULDER, Colo.

Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid growth prospects.